MP72-13 SHIP-1 ACTIVATION PROVIDES SIGNIFICANT BENEFIT IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: RESULTS OF A PHASE 2 RANDOMIZED PLACEBO CONTROLLED TRIAL

The Journal of Urology ◽

10.1016/j.juro.2016.02.1626 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

J. Curtis Nickel ◽

Blair Egerdie ◽

Edward Davis ◽

Robert Evans ◽

Heidi Biagi ◽

...

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Significant Benefit ◽

Phase 2 ◽

Download Full-text

Faculty of 1000 evaluation for A Randomized, Double-Blind, Placebo Controlled Trial of Adalimumab in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718022125.793480106 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

Commentary: Efficacy of Clorpactin in refractory bladder pain syndrome/interstitial cystitis: a randomized controlled trial

International Urogynecology Journal ◽

10.1007/s00192-021-04731-z ◽

2021 ◽

Author(s):

Mittal Patel

Keyword(s):

Randomized Controlled Trial ◽

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Bladder Pain ◽

Randomized Controlled

Download Full-text

Prospective randomized controlled trial comparing the effect of fulguration versus fulguration and hydrodistension in Interstitial Cystitis/Bladder Pain Syndrome

European Urology Supplements ◽

10.1016/s1569-9056(19)30037-5 ◽

2019 ◽

Vol 18 (1) ◽

pp. e51-e52

Author(s):

H.S. Son ◽

H. Yoon ◽

J.H. Kim

Keyword(s):

Randomized Controlled Trial ◽

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Bladder Pain ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial

Download Full-text

822 RANDOMIZED CONTROLLED TRIAL FOR EFFICACY OF BOTULINUM TOXIN TYPE A IN TREATMENT OF PATIENTS SUFFERING BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS WITH HUNNERS' LESIONS PRELIMINARY RESULTS

The Journal of Urology ◽

10.1016/j.juro.2012.02.912 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

George Kasyan ◽

Dmitry Pushkar

Keyword(s):

Randomized Controlled Trial ◽

Botulinum Toxin ◽

Interstitial Cystitis ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Pain Syndrome ◽

Botulinum Toxin Type ◽

Bladder Pain Syndrome ◽

Bladder Pain ◽

Randomized Controlled

Download Full-text

PD01-01 RESULTS FROM A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE EFFICACY AND SAFETY OF INTRA-TRIGONAL INJECTION OF ONABOTULINUM TOXIN A IN PATIENTS WITH BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS.

The Journal of Urology ◽

10.1016/j.juro.2017.02.181 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Rui Pinto ◽

Daniel Costa ◽

Afonso Morgado ◽

Pedro Pereira ◽

João Silva ◽

...

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Efficacy And Safety ◽

Toxin A ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo ◽

Onabotulinum Toxin A

Download Full-text

PD9-11 A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF ADALIMUMAB IN THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

The Journal of Urology ◽

10.1016/j.juro.2014.02.793 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Philip Bosch

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

271 A randomised controlled trial to evaluate the efficacy of botulinum toxin type A in the treatment of patients suffering bladder pain syndrome/interstitial cystitis with Hunner's lesions: Preliminary results

European Urology Supplements ◽

10.1016/s1569-9056(12)60268-1 ◽

2012 ◽

Vol 11 (1) ◽

pp. e271-e271a ◽

Author(s):

A.V. Zaitcev ◽

G.R. Kasyan ◽

O. Tsibulya ◽

D.Y. Pushkar

Keyword(s):

Botulinum Toxin ◽

Randomised Controlled Trial ◽

Interstitial Cystitis ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Pain Syndrome ◽

Botulinum Toxin Type ◽

Bladder Pain Syndrome ◽

Bladder Pain ◽

Randomised Controlled

Download Full-text

A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome

European Urology ◽

10.1016/j.eururo.2018.07.026 ◽

2018 ◽

Vol 74 (5) ◽

pp. 623-630 ◽

Author(s):

Philip C. Bosch

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Certolizumab Pegol ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial

European Urology ◽

10.1016/j.eururo.2020.01.002 ◽

2020 ◽

Vol 77 (5) ◽

pp. 644-651 ◽

Author(s):

Kwang Jin Ko ◽

Won Jin Cho ◽

Young-Suk Lee ◽

Joongwon Choi ◽

Hye Jin Byun ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Interstitial Cystitis ◽

Transurethral Resection ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Bladder Pain ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718022125.793482012 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text